Asia Pacific Tops Regional Growth at 6.8% CAGR as North America Holds 40.9% of Revenue
Pneumococcal Vaccine Market size was valued at USD 9.16 billion in 2025 and is projected to grow from USD 9.61 billion in 2026 to USD 14.57 billion by 2034, exhibiting a CAGR of 5.30%, according to Polaris Market Research. Pneumococcal vaccines protect against infections caused by Streptococcus pneumoniae, including pneumonia, meningitis, bacteremia and otitis media. They introduce safe...
0 Comentários 0 Compartilhamentos 28 Visualizações 0 Anterior